# A Study of Sonodynamic Therapy Using SONALA-001 and Exablate 4000 Type 2.0 in Subjects With Recurrent GBM

> **NCT05370508** · PHASE1,PHASE2 · TERMINATED · sponsor: **SonALAsense, Inc.** · enrollment: 8 (actual)

## Conditions studied

- Recurrent GBM

## Interventions

- **COMBINATION_PRODUCT:** SONALA-001 (ALA) and MR-Guided Focused Ultrasound device (MRgFUS)

## Key facts

- **NCT ID:** NCT05370508
- **Lead sponsor:** SonALAsense, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2023-02-06
- **Primary completion:** 2024-06-11
- **Final completion:** 2024-07-08
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** Study is terminated due to funding challenges and not due to safety concerns.
- **Last updated:** 2024-07-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05370508

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05370508, "A Study of Sonodynamic Therapy Using SONALA-001 and Exablate 4000 Type 2.0 in Subjects With Recurrent GBM". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05370508. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*